Dr Jay Stone was previously a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme, and is now Press and Public Enquiries Officer at the Human Fertilisation and Embryology Authority. She obtained her PhD at University College London's Institute of Ophthalmology, where she researched gene abnormalities in retinal vascular angiogenesis as part of the Graduate Programme of the Medical Research Council's Laboratory for Molecular Cell Biology. She has also written for the journals Opticon1826 and Prometheus, and for the British Society of Cell Biology. She has collaborated with designer Berit Greinke on the project The Good, the Bad and the Negative, which was exhibited at the Science Museum's Dana Centre and went on to receive the NOBELini award. Previously, she studied Molecular Medicine at the University of Sussex and interned at Sense About Science. Her BioNews article 'First saviour sibling stem cell transplant performed in UK' is reproduced in Biotechnology and Cloning (buy this book from Amazon UK). She tweets as @JS_tone
Edwina Hart, the Welsh Assembly Minister for Health and Social Services, has said that some women in Wales at increased risk of developing hereditary breast cancer are having to wait up to three years to get their genetic test results, while English women are waiting only eight weeks....
Dr R. Scott Turner and his team of the Memory Disorders Program at Georgetown University, US, have begun recruiting patients to take part in a gene therapy trial, which hopes to test whether gene therapy using the nerve growth factor (NGF) gene could be used to slow the progression of Alzheimer's disease...
Doctors might soon be offered reduced price DNA analysis from genetic profiling companies such as 23andme, in the hope that this will better equip them to answer any questions their patients have about the tests and the results that cause concern....
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
